These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23389083)

  • 1. Olmesartan-based therapies: an effective way to improve blood pressure control and cardiovascular protection.
    de la Sierra A; Volpe M
    J Hypertens; 2013 Mar; 31 Suppl 1():S13-7. PubMed ID: 23389083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple combination therapy to improve blood pressure control: experience with olmesartan-amlodipine-hydrochlorothiazide therapy.
    Tocci G; Paneni F; Passerini J; Volpe M
    Expert Opin Pharmacother; 2012 Dec; 13(18):2687-97. PubMed ID: 23170911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olmesartan/amlodipine: blood pressure lowering and beyond in special populations.
    Erdine S
    Ther Adv Cardiovasc Dis; 2012 Feb; 6(1):31-44. PubMed ID: 22222315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple Combination Therapies Based on Olmesartan: A Personalized Therapeutic Approach to Improve Blood Pressure Control.
    Volpe M; Santolamazza C; Mastromarino V; Coluccia R; Battistoni A; Tocci G
    High Blood Press Cardiovasc Prev; 2017 Sep; 24(3):255-263. PubMed ID: 28608025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olmesartan medoxomil plus hydrochlorothiazide for treating hypertension.
    Barrios V; Escobar C
    Expert Opin Pharmacother; 2008 Jan; 9(1):129-36. PubMed ID: 18076344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II receptor blocker-based therapy in Japanese elderly, high-risk, hypertensive patients.
    Ogawa H; Kim-Mitsuyama S; Matsui K; Jinnouchi T; Jinnouchi H; Arakawa K;
    Am J Med; 2012 Oct; 125(10):981-90. PubMed ID: 22503610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fixed-combination therapy to improve blood pressure control: experience with olmesartan-based therapy.
    Tocci G; Volpe M
    Expert Rev Cardiovasc Ther; 2011 Jul; 9(7):829-40. PubMed ID: 21809963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ARB-based single-pill platform to guide a practical therapeutic approach to hypertensive patients.
    Volpe M; de la Sierra A; Kreutz R; Laurent S; Manolis AJ
    High Blood Press Cardiovasc Prev; 2014 Jun; 21(2):137-47. PubMed ID: 24532183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monotherapy and Dual Combination Therapies Based on Olmesartan: A Comprehensive Strategy to Improve Blood Pressure Control.
    Volpe M; Santolamazza C; Mastromarino V; Coluccia R; Battistoni A; Tocci G
    High Blood Press Cardiovasc Prev; 2017 Sep; 24(3):243-253. PubMed ID: 28608026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of olmesartan/amlodipine combination therapy in patients with mild-to-severe hypertension: focus on 24-h blood pressure control.
    Parati G; Ochoa JE; Ramos C; Hoshide S; Lonati L; Bilo G
    Ther Adv Cardiovasc Dis; 2010 Oct; 4(5):301-13. PubMed ID: 20921092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olmesartan/Amlodipine: combination therapy for the treatment of hypertension [corrected].
    Pimenta E
    Adv Ther; 2009 Jan; 26(1):1-11. PubMed ID: 19129998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tribenzor for hypertension.
    Med Lett Drugs Ther; 2010 Sep; 52(1346):70-1. PubMed ID: 20814402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
    Neutel J; Shojaee A; Maa JF
    Adv Ther; 2012 Jun; 29(6):508-23. PubMed ID: 22773358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beating the clock: reducing cardiovascular risk by rapid blood pressure reduction with olmesartan.
    Barrios V; Escobar C
    Expert Opin Pharmacother; 2010 Jun; 11(9):1549-58. PubMed ID: 20446761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Sevikar® compared to the combination of perindopril plus amlodipine on central arterial blood pressure in patients with moderate-to-severe hypertension: Rationale and design of the SEVITENSION study.
    Ruilope LM; Schaefer A
    Contemp Clin Trials; 2011 Sep; 32(5):710-6. PubMed ID: 21586342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of olmesartan in combination therapy in blood pressure control and vascular function.
    Ferrario CM; Smith RD
    Vasc Health Risk Manag; 2010 Sep; 6():701-9. PubMed ID: 20859541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difficult-to-control hypertension: effects of olmesartan-based combination therapies.
    de la Sierra A
    J Hypertens; 2013 Mar; 31 Suppl 1():S1-2. PubMed ID: 23389082
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.